Life Science Today

Crohn’s approval, new VC round, direct offerings, and potential asset sales.
 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
AbbVie
Third Rock
Scholar Rock
Kyowa Kirin

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Gene therapy, minor legislation, a $625M series D, and four companies raise $373M.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
BlueBird
FDA
Resilience
Corvia, Code, Mineralys, Tessa

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Pharma buys, pharma splits, pharma trades, and oncology biobucks from pharma

Find out more at
https://LifeScienceTodayPodcast.com

Story References
GSK + Affinivax
Pfizer – Haleon
Regeneron
Roche + Repare

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

Pox progress, an oncology acquisition, and we look at $360M worth of biotech funding

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Chimerix, Emergent, SIGA
Merck & Kelun
Inceptor, Laekna, Kriya

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

An $11.6B yes, $11.7B delay, drop the A1C with GLP, and a billion bio-bucks

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Pfizer + Biohaven
Regulators
Lilly
BridgeBio + BMS

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Resets for biotech, antibiotics approval not enough, continued consolidation, and a normal deal


Find out more at
https://LifeScienceTodayPodcast.com

Story References
Zymeworks
Phathom
Catalyst
CenExel
Intercept + Advanz

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Pharma Q1 reports are rolling in, COVID boost turned sustainable, and weight loss battle looms

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Merck
Sanofi
J&J
ThermoFisher
Novo Nordisk
Eli Lilly

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Drops for reading, a $220M raise, and an acquisition straight out of the movies

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Orasis
Reify
Blackrock + MindX

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

The FDA asks for more diversity, $1B for injectors, $2B for a one-trick pony, and $68M to make DNA. 

Find out more at
https://LifeScienceTodayPodcast.com

Story References
FDA
Antares + Halozyme
GSK + Sierra
Ansa Biotechnologies

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Viral therapies, rare disease approvals, and lab space premiums

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Pfizer + ReViral
Novartis
Charles River + Explora Labs

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.